Sangamo Therapeutics Inc. buy Wells Fargo & Company
Start price
10.08.23
/
50%
€0.99
Target price
10.08.24
€3.63
Performance (%)
-6.87%
End price
11.08.24
€0.92
Summary
This prediction ended on 11.08.24 with a price of €0.92. With a performance of -6.87%, the BUY prediction for Sangamo Therapeutics Inc. by Wells_Fargo___Compan closed slightly in the red. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -15.248% | -15.248% | -58.174% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Wells Fargo & Company from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten